Skip to content
The Policy VaultThe Policy Vault

Xiaflex (collagenase clostridium histolyticum)Point32Health

Peyronie’s disease

Initial criteria

  • Documented diagnosis of Peyronie’s disease
  • Documentation of a palpable plaque
  • Documentation that curvature deformity is at least 30 degrees prior to initiating Xiaflex therapy
  • Prescribed by or in consultation with a urologist
  • Patient age ≥ 18 years
  • Documentation the patient has intact erectile function (with or without medication)
  • Documentation the patient will receive a maximum of one treatment course with a maximum of 8 injections total, including any injections received for any previous treatment

Approval duration

12 months